Type I IFN stimulated by activation of the viral pattern recognition receptors (PRRs) retinoic acid-inducible gene I (RIG-I) and stimulator of interferon genes (STING) is protective against intestinal barrier damage and prevented graft-versus-host disease (GvHD) in mice (78). This evidence concerns the gene RIGI and graft versus host disease.